Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jun 24;15(13):3324.
doi: 10.3390/cancers15133324.

Expression Analysis of hsa-miR-181a-5p, hsa-miR-143-3p, hsa-miR-132-3p and hsa-miR-23a-3p as Biomarkers in Colorectal Cancer-Relationship to the Body Mass Index

Affiliations

Expression Analysis of hsa-miR-181a-5p, hsa-miR-143-3p, hsa-miR-132-3p and hsa-miR-23a-3p as Biomarkers in Colorectal Cancer-Relationship to the Body Mass Index

Sofía Elena Tesolato et al. Cancers (Basel). .

Abstract

This work aims to investigate the expression levels of four preselected miRNAs previously linked to cancer and/or obesity, with the purpose of finding potential biomarkers in the clinical management of CRC developed by patients showing different BMI values. We analyzed samples from a total of 65 subjects: 43 affected by CRC and 22 without cancer. Serum and both subcutaneous and omental adipose tissues (SAT and OAT) were investigated, as well as tumor and non-tumor colorectal tissues in the case of the CRC patients. The relative expression (2-∆∆Ct) levels of 4 miRNAs (hsa-miR-181a-5p, hsa-miR-143-3p, has-miR-132-3p and hsa-miR-23a-3p) were measured by RT-qPCR. Serum, SAT and OAT expression levels of these miRNAs showed significant differences between subjects with and without CRC, especially in the group of overweight/obese subjects. In CRC, serum levels of hsa-miR-143-3p clearly correlated with their levels in both SAT and OAT, independently of the BMI group. Moreover, hsa-miR-181a-5p could be considered as a biomarker in CRC patients with BMI ≥ 25 Kg/m2 and emerges as a tumor location marker. We conclude that both adiposity and CRC induce changes in the expression of the miRNAs investigated, and hsa-miR-143-3p and hsa-miR-181a-5p expression analysis could be useful in the clinical management of CRC.

Keywords: adipose tissue; colorectal cancer; miRNAs; obesity; serum biomarkers.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Correlations (Spearman test) between miRNA levels in serum and adipose tissues (subcutaneous, SAT; and omental, OAT) of colorectal cancer patients, for hsa-miR-181a-5p (A,B), hsa-miR-143-3p (C,D) and hsa-miR-23a-3p (E,F).
Figure 2
Figure 2
Correlations in miRNA levels between both adipose tissues (subcutaneous and omental) of colorectal cancer patients, for hsa-miR-181a-5p (A), hsa-miR-143-3p (B), hsa-miR-132-3p (C) and hsa-miR-23a-3p (D). 1 Pearson’s correlation test; 2 Spearman’s correlation test.

References

    1. Sung H., Ferlay J., Siegel R.L., Laversanne M., Soerjomataram I., Jemal A., Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin. 2021;71:209–249. doi: 10.3322/caac.21660. - DOI - PubMed
    1. Dekker E., Tanis P.J., Vleugels J.L.A., Kasi P.M., Wallace M.B. Colorectal cancer. Lancet. 2019;394:1467–1480. doi: 10.1016/S0140-6736(19)32319-0. - DOI - PubMed
    1. Ackerman S.E., Blackburn O.A., Marchildon F., Cohen P. Insights into the Link Between Obesity and Cancer. Curr. Obes. Rep. 2017;6:195–203. doi: 10.1007/s13679-017-0263-x. - DOI - PubMed
    1. Gebert L.F.R., MacRae I.J. Regulation of microRNA function in animals. Nat. Rev. Mol. Cell. Biol. 2019;1:21–37. doi: 10.1038/s41580-018-0045-7. - DOI - PMC - PubMed
    1. Lizarbe M.A., Calle-Espinosa J., Fernández-Lizarbe E., Fernández-Lizarbe S., Robles M.Á., Olmo N., Turnay J. Colorectal Cancer: From the Genetic Model to Posttranscriptional Regulation by Noncoding RNAs. Biomed. Res. Int. 2017;2017:7354260. doi: 10.1155/2017/7354260. - DOI - PMC - PubMed